Skip to content
Search

Latest Stories

Submit Guest Post

Doctors, nurses tested positive for COVID-19; Mumbai hospital sealed

THE Wockhardt Hospital in Mumbai was sealed on Monday (6) after 26 nurses and three doctors tested positive for coronavirus.

No one is allowed to enter or exit the private hospital.


Two nurses working in the same general ICU ward tested positive for Covid-19 on March 28. According to reports, the infections spread after that.

The Brihanmumbai Municipal Corporation (BMC) had declared the hospital as a containment zone on Sunday.

Suresh Kakani, additional municipal commissioner (health), BMC, said they have sealed the hospital and the staffers are not allowed to go out until they test negative for a coronavirus test.

“It is the fault of the hospital administration that they didn’t take precautionary measures, due to which nearly 300 staffers have been quarantined. We have also set up a team to probe how the virus spread among so many people in a hospital setting,” he said.

Meanwhile, the Covid-19 positive nurses alleged that due to the negligence of the hospital, the infection spread to other staffers.

On March 20 two suspected and positive Covid-19 patients were brought to the hospital from Kasturba Gandhi Hospital. The confirmed cases were kept in isolation wards, while suspects were kept in general ICU wards where non-Covid-19 patients were also being provided care.

On March 28, two nurses working in the same general ICU ward tested positive for Covid-19. Soon, 10 nurses got infected and later the infection spread to 26 nurses and three doctors.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weight loss pill

Foundayo is the latest GLP-1 treatment to receive UK approval in tablet form

Representational image: iStock

UK becomes first European nation to approve new weight-loss pill, but NHS access is still pending

  • The UK is the first European country to approve Eli Lilly’s Foundayo pill.
  • The tablet is taken once a day without food or water restrictions.
  • NHS availability will depend on a separate NICE assessment.

The UK has become the first European nation to approve a new daily weight-loss pill, giving patients another option beyond the injectable treatments that have dominated the GLP-1 market.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s orforglipron, sold under the brand name Foundayo, on August 10 for weight management and to improve blood sugar control in adults with type 2 diabetes.

Keep ReadingShow less